Molina Healthcare of Illinois Invests $2.4 Million in Community-Based Organizations
Molina Healthcare of Illinois, in partnership with The MolinaCares Accord, is investing $2.4 million to support community health initiatives across the state.
Stocks · News reference
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Molina Healthcare of Illinois, in partnership with The MolinaCares Accord, is investing $2.4 million to support community health initiatives across the state.
Fidelis Care, a Centene Corporation company, has awarded $140,000 in grants to support maternal health initiatives across New York State.
Noble Mineral Exploration Inc. has appointed Stephen Balch, a co-founder of Canada Nickel Company Inc., as a Strategic Advisor to support its exploration programs and corporate development.
Ondas Inc. (ONDS) raised its 2026 revenue guidance to at least $550M following Q3 revenues of $167.5M, up 16-fold year-over-year. The company expects Q4 revenues exceeding $250M, supported by an $835M backlog and $214M in new orders. However, adjusted gross margins declined to 34.8% and adjusted EBITDA losses widened to $59.7M, signaling profitability challenges despite strong top-line growth.
Ondas Holdings (ONDS) targets $550M in 2026 revenues and $1.1B in 2027 with organic growth above 40%, backed by an $835M backlog. However, the company faces widening EBITDA losses, rising costs, and M&A integration challenges. Analysts recommend a hold-and-watch approach pending evidence of operating leverage and profitability.
Ondas Inc. (ONDS) reported Q3 2026 revenues of $167.5 million with an $835 million backlog, raising 2026 guidance to $550 million and 2027 target to $1.1 billion. However, the stock fell 17.8% post-earnings due to widening EBITDA losses ($59.7 million), gross margin compression (21.8%), and significant cash burn ($278 million in nine months). While the company benefits from strong defense demand and acquisition-driven growth, execution risks and profitability challenges warrant caution.